Compare Inovio Pharmaceuticals Inc (INO) vs Reddit Inc (RDDT) Price & Performance

INO trades at $0.772, up 4.83% in the last 24 hours, but technical indicators signal a bearish trend. The company shows minimal revenue of $65,340 in 2025 with a net loss of $84.95 million, though it has beaten EPS estimates in recent quarters. Key developments include an upcoming Q2 2026 earnings report on August 12, 2026, and a pending FDA decision on INO-3107 by October 30, 2026.

The outlook hinges on FDA approval of INO-3107, with a consensus price target of $3.25 implying significant upside. However, high cash burn, negative margins, and legal scrutiny pose substantial risks. Investors should weigh the binary event against persistent financial challenges.

Reddit (RDDT) trades at $153.46, down 3.3% in the past 24 hours amid bearish technical signals. The company demonstrates strong fundamentals with 61% YoY revenue growth in Q2 2026 and consistent earnings beats, though recent CEO share sales and search traffic concerns have pressured the stock. Technical indicators show resistance at $160 with support at $154, while fundamentals reveal robust profitability with 91.44% gross margins and 31.35% net income margins.

Despite near-term volatility, Reddit's growth trajectory and AI integration opportunities support long-term upside potential. The consensus price target of $220.25 implies 43% upside, though risks include user growth sustainability and competitive pressures. With no sell ratings from 28 covering analysts and strong institutional interest, the stock presents a compelling growth opportunity for patient investors.